Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Classification of human tumors using gene expression profiles obtained after microarray analysis of fine-needle aspiration biopsy samples.

Centeno BA, Enkemann SA, Coppola D, Huntsman S, Bloom G, Yeatman TJ.

Cancer. 2005 Apr 25;105(2):101-9.

2.

Total RNA yield and microarray gene expression profiles from fine-needle aspiration biopsy and core-needle biopsy samples of breast carcinoma.

Symmans WF, Ayers M, Clark EA, Stec J, Hess KR, Sneige N, Buchholz TA, Krishnamurthy S, Ibrahim NK, Buzdar AU, Theriault RL, Rosales MF, Thomas ES, Gwyn KM, Green MC, Syed AR, Hortobagyi GN, Pusztai L.

Cancer. 2003 Jun 15;97(12):2960-71.

3.

Development of a microarray platform for FFPET profiling: application to the classification of human tumors.

Duenwald S, Zhou M, Wang Y, Lejnine S, Kulkarni A, Graves J, Smith R, Castle J, Tokiwa G, Fine B, Dai H, Fare T, Marton M.

J Transl Med. 2009 Jul 28;7:65. doi: 10.1186/1479-5876-7-65.

4.

Development and validation of a method for using breast core needle biopsies for gene expression microarray analyses.

Ellis M, Davis N, Coop A, Liu M, Schumaker L, Lee RY, Srikanchana R, Russell CG, Singh B, Miller WR, Stearns V, Pennanen M, Tsangaris T, Gallagher A, Liu A, Zwart A, Hayes DF, Lippman ME, Wang Y, Clarke R.

Clin Cancer Res. 2002 May;8(5):1155-66.

5.

A preliminary result of three-dimensional microarray technology to gene analysis with endoscopic ultrasound-guided fine-needle aspiration specimens and pancreatic juices.

Nonogaki K, Itoh A, Kawashima H, Ohno E, Ishikawa T, Matsubara H, Itoh Y, Nakamura Y, Nakamura M, Miyahara R, Ohmiya N, Ishigami M, Katano Y, Goto H, Hirooka Y.

J Exp Clin Cancer Res. 2010 Apr 25;29:36. doi: 10.1186/1756-9966-29-36.

6.

The feasibility of using fine needle aspiration from primary breast cancers for cDNA microarray analyses.

Assersohn L, Gangi L, Zhao Y, Dowsett M, Simon R, Powles TJ, Liu ET.

Clin Cancer Res. 2002 Mar;8(3):794-801.

7.

The effects of timing of fine needle aspiration biopsies on gene expression profiles in breast cancers.

Wong V, Wang DY, Warren K, Kulkarni S, Boerner S, Done SJ, Leong WL.

BMC Cancer. 2008 Sep 30;8:277. doi: 10.1186/1471-2407-8-277.

8.

Fine-needle aspiration biopsy of non-Hodgkin lymphoma for use in expression microarray analysis.

Morrison C, Palatini J, Riggenbach J, Radmacher M, Porcu P.

Cancer. 2006 Oct 25;108(5):311-8.

10.
11.

Feasibility of using low-volume tissue samples for gene expression profiling of advanced non-small cell lung cancers.

Lim EH, Aggarwal A, Agasthian T, Wong PS, Tan C, Sim E, Tan L, Goh PS, Wang SC, Khoo KL, Mukherjee A, Khoo SM, Chua G, Nilsson B, Lee KH, Tan P.

Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):5980-7.

12.

Increased yield of total RNA from fine-needle aspirates for use in expression microarray analysis.

Dunmire V, Wu C, Symmans WF, Zhang W.

Biotechniques. 2002 Oct;33(4):890-2, 894, 896.

PMID:
12398198
13.

RNA expression analysis of formalin-fixed paraffin-embedded tumors.

Penland SK, Keku TO, Torrice C, He X, Krishnamurthy J, Hoadley KA, Woosley JT, Thomas NE, Perou CM, Sandler RS, Sharpless NE.

Lab Invest. 2007 Apr;87(4):383-91. Epub 2007 Feb 12.

14.

RNA quality and gene expression analysis of ovarian tumor tissue undergoing repeated thaw-freezing.

Jochumsen KM, Tan Q, Dahlgaard J, Kruse TA, Mogensen O.

Exp Mol Pathol. 2007 Feb;82(1):95-102. Epub 2006 Jul 13.

PMID:
16842777
15.
16.

Telomerase activity in fine needle aspiration biopsy samples: application to diagnosis of human thyroid carcinoma.

Guerra LN, Miler EA, Moiguer S, Karner M, Orlandi AM, Fideleff H, Burdman JA.

Clin Chim Acta. 2006 Aug;370(1-2):180-4. Epub 2006 Mar 6. Erratum in: Clin Chim Acta. 2007 Sep;384(1-2):188.

PMID:
16600201
17.

Comparative expression of a set of genes to an internal housekeeping control in CDNA amplified and not amplified by PolyAPCR in non-Hodgkin's lymphoma samples obtained from fine-needle aspiration cytology.

Corbi FC, Inaoka RJ, Felix RS, Andrade VC, Etto LY, Vettore AL, Franco MF, Colleoni GW.

Diagn Mol Pathol. 2010 Mar;19(1):40-4. doi: 10.1097/PDM.0b013e3181b0b618.

PMID:
20186011
18.

Large scale real-time PCR validation on gene expression measurements from two commercial long-oligonucleotide microarrays.

Wang Y, Barbacioru C, Hyland F, Xiao W, Hunkapiller KL, Blake J, Chan F, Gonzalez C, Zhang L, Samaha RR.

BMC Genomics. 2006 Mar 21;7:59.

19.

Discriminate gene lists derived from cDNA microarray profiles of limited samples permit distinguishing mesenchymal neoplasia ex vivo.

Joyner DE, Wade ML, Szabo A, Bastar J, Coffin CM, Albritton KH, Bernard PS, Randall RL.

J Cancer Res Clin Oncol. 2005 Mar;131(3):137-46. Epub 2004 Dec 22.

PMID:
15614524
20.

Biologically relevant effects of mRNA amplification on gene expression profiles.

van Haaften RI, Schroen B, Janssen BJ, van Erk A, Debets JJ, Smeets HJ, Smits JF, van den Wijngaard A, Pinto YM, Evelo CT.

BMC Bioinformatics. 2006 Apr 11;7:200.

Supplemental Content

Support Center